Vaccine advisers to the Centers for Disease Control and Prevention have scheduled an emergency meeting for next week to discuss coronavirus vaccines.
The Advisory Committee on Immunization Practices (ACIP) plans a meeting for Wednesday, January 27, to discuss progress in administering vaccine doses, safety of the vaccines, testing of the vaccines in children and studies on the effectiveness of the vaccine.
There is also a time slot for a Covid-19 vaccine manufacturer to present, but the name of the manufacturer is to be determined. Johnson & Johnson is expected to report on Phase 3 clinical trials for its experimental coronavirus vaccine by the end of the month.
ACIP members are not expected to vote during the one-day meeting, a CDC spokeswoman said.